Two versions of a Chlamydia vaccine have just been rendered safe, per a new study of three dozen healthy women.
Chlamydia is one of the most commonly sexually transmitted diseases and can cause disabling, long-term complications for women. About 131 million women and men are newly infected globally each year.
The fact both vaccines produced an immune response is extremely encouraging, says pediatric infectious disease specialist Toni Darville of the University of North Carolina School of Medicine in Chapel Hill.
The discovery could have a significant long-term effect on public health, especially since reported numbers for Chlamydia infections are often lower since infections go unreported.